Table 1.
Association between DNMT3B Expression and the Clinicopathological Features of NPC Patients
| Feature | Total | DNMT3B |
p Value | |
|---|---|---|---|---|
| Low Expression | High Expression | |||
| Age (years) | ||||
| ≥45 | 77 | 23 | 54 | 0.898 |
| <45 | 55 | 17 | 38 | |
| Sex | ||||
| Male | 101 | 36 | 65 | 0.029 |
| Female | 31 | 4 | 27 | |
| Histologic Classification | ||||
| U | 116 | 36 | 80 | 0.840 |
| D | 16 | 4 | 12 | |
| N Category | ||||
| N0 | 36 | 11 | 25 | 0.969 |
| N1–3 | 96 | 29 | 67 | |
| Metastasis | ||||
| No | 111 | 39 | 72 | 0.004 |
| Yes | 21 | 1 | 20 | |
| Clinical Stage | ||||
| I+II | 72 | 29 | 43 | 0.006 |
| III+IV | 60 | 11 | 49 | |
NPC, nasopharyngeal carcinoma; U, undifferentiated non-keratinized carcinoma; D, differentiated non-keratinized carcinoma.